- 1/15/2020 - Pediatric Study Plans for Oncology Drugs: Transitional Information Until Full Implementation of FDARA Section 504 Questions and Answers: Draft Guidance for Industry
- 1/13/2020 - Peripheral Percutaneous Transluminal Angioplasty (PTA) and Specialty Catheters - Premarket Notification (510(k)) Submissions: Draft Guidance for Industry and Food and Drug Administration Staff
viernes, 17 de enero de 2020
Recently Posted Guidance Documents
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario